Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Light Therapy Market size to grow by USD 201.87 Mn | Availability of Compatible Products to Boost Growth | Technavio


NEW YORK, Oct. 25, 2021 /PRNewswire/ -- The light therapy market size is set to grow by USD 201.87 million from 2021 to 2025, according to Technavio. The report offers a detailed analysis of the market in optimistic, probable, and pessimistic forecast scenarios.

Buy our full report for an up-to-date analysis regarding the current global market scenario and the overall market environment.
Start by Downloading a Free Sample

Factors such as the growing prevalence of SAD and the growing prevalence of skin disorders will offer immense growth opportunities. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments. The light therapy market is fragmented, and the degree of fragmentation will decelerate during the forecast period.

Light Therapy Market 2021-2025: Segmentation

Get insights on the growth contribution of each segment and make informed business decisions.
Download a Free Sample Report to Gain Confidence

Light Therapy Market 2021-2025: Vendor Analysis and Scope

Some of the major vendors of the light therapy market in the healthcare equipment industry include Beurer GmbH, Biophotas Inc., Johnson and Johnson Inc., Koninklijke Philips NV, Lucimed SA, Lumie, Northern Light Technologies, Red Light Man Ltd., and Verilux Inc. To help businesses improve their market position, Technavio's report provides a detailed analysis of around 25 vendors operating in the market. Backed with competitive intelligence and benchmarking, our research reports on the light therapy market are designed to provide entry support, customer profile & M&As as well as go-to-market strategy support.

The report also covers the following areas:

The light therapy market is fragmented, and the degree of fragmentation will decelerate. The availability of compatible products will offer immense growth opportunities. However, the low awareness about light therapy will hamper the market growth.

Get lifetime access to our Technavio Insights. Subscribe now to our most popular "Lite Plan" billed annually at USD 3000. View 3 reports monthly and Download 3 Reports Annually!

Light Therapy Market 2021-2025: Key Highlights

Related Reports:
Global Ophthalmic Femtosecond Lasers Market
 - Global ophthalmic femtosecond lasers market is segmented by product (consumables and accessories and equipment), application (refractive surgery and cataract surgery), end-user (hospitals, eye care centers, and ASCs), and geography (Asia, Europe, North America, and ROW).
Download Exclusive Free Sample Report

Global Urology Laser Surgical Devices Market - Global urology laser surgical devices market is segmented by product (portable laser surgical devices and table-top laser surgical devices) and geography (Asia, Europe, North America, and ROW).
Download Exclusive Free Sample Report

Light Therapy Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Decelerate at a CAGR of over 4%

Market growth 2021-2025

USD 201.87 million

Market structure

Fragmented

YoY growth (%)

6.97

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 52%

Key consumer countries

US, Germany, Japan, China, and UK

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Beurer GmbH, Biophotas Inc., Johnson and Johnson Inc., Koninklijke Philips NV, Lucimed SA, Lumie, Northern Light Technologies, Red Light Man Ltd., and Verilux Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact:
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...



News published on and distributed by: